Kolexia
Guincestre Thomas Néphrologie
Guincestre Thomas
Néphrologie
Centre Hospitalier de Roubaix
Roubaix, France
38 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glomérulonéphrite COVID-19 Hyperparathyroïdie Hyperparathyroïdie secondaire Insuffisance rénale Maladies du rein Insuffisance rénale chronique Hypertension artérielle Vascularite

Collaborateurs

Voir plus
Glowacki Francois-Xavier
Glowacki Francois-Xavier
Hôpital Huriez, Lille, France
Bourdon Franck
Bourdon Franck
Hôpital Seclin Carvin, Seclin, France
Francois Alexis
Francois Alexis
Centre Hospitalier de Roubaix, Roubaix, France
Azar Raymond
Azar Raymond
Centre Hospitalier de Dunkerque, Dunkerque, France

Industries

Voir plus
Fresenius Medical Care
1 collaboration(s)
Dernière en 2021
American Medical Technologies
1 collaboration(s)
Dernière en 2023
Otsuka
1 collaboration(s)
Dernière en 2020
GSK
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
THINK: Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease: an Open Label, a Cluster Randomized Controlled, Phase 3 Trial
Essai Clinique (CHU Tours)   25 octobre 2023
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases.
Clinical kidney journal   06 mai 2022
MO116: Vitamin C Nephrotoxicity in a COVID-19 Patient: A Case Report
59th ERA Congress, 19-22 May 2022: Congress Abstracts   03 mai 2022
Early Renal Recovery after the First Flare of Pauci-Immune Glomerulonephritis.
American journal of nephrology   17 janvier 2022
MO282EARLY RENAL RECOVERY AFTER A FIRST FLARE OF PAUCI IMMUNE GLOMERULONEPHRITIS
58th ERA-EDTA Congress, 5–8 June 2021   29 mai 2021
Spondyloarthritis-Associated IgA Nephropathy.
Kidney international reports   16 mars 2020
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
Kidney international   09 novembre 2019
Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study.
Clinical kidney journal   18 mars 2019
Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   20 octobre 2017
Contrôle de la PTH en vie réelle chez des patients hémodialysés atteints d’hyperparathyroïdie secondaire traitée par cinacalcet : étude Mimosa
Deuxième congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT) 2017   01 septembre 2017